Latest Industry Insights

In this interview, we explore the relationship between allergies and mental health, and how advances in diagnostic testing could help clinicians offer more personalized patient care.

Discover insights on the challenges of CTCs and ctDNA from liquid biopsies as cancer diagnostic tools, how novel technology is helping to overcome some of these issues and the future monitoring landscape.

Technology Networks spoke with Stefan Foser, vice president of global pharma at Bruker, to explore how they integrate instrumentation, software and consumables to support early-stage pharma innovation.

Learn how Bruker’s latest innovations are enhancing small molecule analysis for toxicology and environmental analysis.

At the recent American Society for Mass Spectrometry conference in Baltimore, Technology Networks sat down with Dr. Nikhil Rao to learn more about Microscoop® Mint, an advanced sample preparation platform.

Dr. Tomek Czernuszewicz shares insights on the limitations of traditional delivery techniques and how Revvity is advancing in vivo imaging through AI-powered tools.

Structure verification by NMR is a vital task in drug discovery but can be slow and subjective. This article explores how ASV transforms it into a scalable, consistent and reliable process.

Explore the clinical impact of accurate vitamin D measurement, how the cobas® Mass Spec solution enhances diagnostic precision and the broader role of clinical mass spectrometry in advancing personalized healthcare.

Chromatography-free mass spectrometry boosts throughput, cuts costs and simplifies drug monitoring – learn how Bruker and RECIPE are leading the way.

In this interview, Morten Bern, chief executive officer of Evosep, discusses the innovations behind the Eno system, the evolving needs of pharmaceutical customers and the growing focus on high-throughput, high-sensitivity proteomics solutions.